To require that high deductible health plan deductibles credit payments made by insureds to purchase out-of-plan prescription drugs, provided the cost paid for such out-of-plan prescription drug is less than the cost would have been if purchased through the high deductible health plan.
An Act concerning the shortage of certain drugs prescribed to treat type ii diabetes. To provide that the Commissioner of Consumer Protection shall adopt regulations to ensure that there is a sufficient supply of dulaglutide and semaglutide to treat patients in this state who have been diagnosed with type II diabetes.
To prohibit certain health carriers from requiring the use of step therapy for prescription drugs prescribed to treat behavioral health conditions or chronic, disabling or life-threatening conditions or diseases.
An Act concerning unannounced closures of retail pharmacies. To ensure that patients are able to access prescription drugs during unannounced closures of retail pharmacies.
To: (1) Establish a state-operated reinsurance program; (2) require the state to apply for a state innovation waiver to fund such program; (3) require the Office of Health Strategy to consider and adjust for any unintended effects or impacts of primary care spending targets on funding for those with developmental disabilities when benchmarking; (4) require the Office of Health Strategy to institute a program for prescription drug benchmarking; and (5) establish a task force to study the impact of spread pricing with prescription drugs and the savings or potential savings under current and alternative [...]
To require pharmacists to inform each patient and the patient's prescribing practitioner regarding the least expensive option for a medication or class of medicine that has been prescribed by the prescribing practitioner and the out-of-pocket cost of such medication or class of medicine if purchased without insurance.
An Act concerning a state-operated reinsurance program and the regulation of health care cost growth. To reduce the cost of health care in this state.
To establish a task force to study antibiotic resistance and funding barriers to the creation of new antibiotic medications.
To: (1) Require the Insurance Department to conduct a study concerning pharmacy benefits managers; (2) require the Insurance Department to conduct a study concerning purchasing pools for prescription drugs and health care supplies; and (3) establish a prescription drug affordability board to monitor prescription drug pricing in this state.
An Act concerning health insurance coverage for epinephrine cartridge injectors, health carriers and pharmacy benefits managers. To place a cap on the cost for epinephrine cartridge injectors.
